Ireland
--:--IST
Enrolling by invitation Observational

Pharmaceutical Literacy and Quality of Life in Spanish Population.

NCT06729697 · tracked via the Priya Life Science Spain tracker
Phase
Observational
Started
2024-11-15
Last updated
2025-04-13

Condition(s) studied

Health Related Quality of LifeLiteracy

Study summary

The goal of this study is to learn about the knowledge and abilities that patients have regarding their own medication and to see if that's related to their quality of life.

The main questions it aims to answer are:

* Are patients abilities and knowledge about their medications sufficient to ensure a safe and efective use?
* Are those knowledge and abilities related to the patient's quality of life? How?

Patients already taking at least one medication will answer questions about their abilities and knowledge towards medication and their quality of life related to their health state.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults currently taking at least one medication prescribed by a physician and living in Spain. Exclusion Criteria: * Having physical or cognitive limitations that make it impossible to answer the study questions.

Primary outcome measure(s)

  • Recognising and Addressing Limited Pharmaceutical Literacy (RALPH) interview guide score — Through study completion, an average of 1 year.
    A quantitative score will be obtained after an interview using the RALPH guide for community pharmacy. Only correct answered questions will add a point to the score. The values obtained stand between 0 and 10, and a higher score means a better outcome.
  • EQ-5D-5L index score — Through study completion, an average of 1 year.
    A health state index score will be calculated from individual health profiles using the Spanish value set (Roudijk B, Ludwig K, Devlin N, Roudijk B, Ludwig K, Devlin N. EQ-5D-5L Value Set Summaries. Value Sets for EQ-5D-5L. 2022;55-212.) where the values stand between -0.166 and 1, and a higher score means a better outcome.

Trial sites (1)

FacilityCityRegionStatus
Clinical Pharmacy and Pharmaceutical Care Unit. Barcelona Barcelona
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06729697 on ClinicalTrials.gov ↗ ← All trials in Spain